78 related articles for article (PubMed ID: 20137945)
1. Synthetic atpenin analogs: Potent mitochondrial inhibitors of mammalian and fungal succinate-ubiquinone oxidoreductase.
Selby TP; Hughes KA; Rauh JJ; Hanna WS
Bioorg Med Chem Lett; 2010 Mar; 20(5):1665-8. PubMed ID: 20137945
[TBL] [Abstract][Full Text] [Related]
2. Q-site inhibitor induced ROS production of mitochondrial complex II is attenuated by TCA cycle dicarboxylates.
Siebels I; Dröse S
Biochim Biophys Acta; 2013 Oct; 1827(10):1156-64. PubMed ID: 23800966
[TBL] [Abstract][Full Text] [Related]
3. Enantioselective total synthesis of atpenin A5.
Ohtawa M; Ogihara S; Sugiyama K; Shiomi K; Harigaya Y; Nagamitsu T; Omura S
J Antibiot (Tokyo); 2009 Jun; 62(6):289-94. PubMed ID: 19373276
[TBL] [Abstract][Full Text] [Related]
4. A common mechanism links differently acting complex II inhibitors to cardioprotection: modulation of mitochondrial reactive oxygen species production.
Dröse S; Bleier L; Brandt U
Mol Pharmacol; 2011 May; 79(5):814-22. PubMed ID: 21278232
[TBL] [Abstract][Full Text] [Related]
5. Ferulenol specifically inhibits succinate ubiquinone reductase at the level of the ubiquinone cycle.
Lahouel M; Zini R; Zellagui A; Rhouati S; Carrupt PA; Morin D
Biochem Biophys Res Commun; 2007 Mar; 355(1):252-7. PubMed ID: 17292330
[TBL] [Abstract][Full Text] [Related]
6. Mitochondrial dehydrogenases in the aerobic respiratory chain of the rodent malaria parasite Plasmodium yoelii yoelii.
Kawahara K; Mogi T; Tanaka TQ; Hata M; Miyoshi H; Kita K
J Biochem; 2009 Feb; 145(2):229-37. PubMed ID: 19060309
[TBL] [Abstract][Full Text] [Related]
7. Atpenins, potent and specific inhibitors of mitochondrial complex II (succinate-ubiquinone oxidoreductase).
Miyadera H; Shiomi K; Ui H; Yamaguchi Y; Masuma R; Tomoda H; Miyoshi H; Osanai A; Kita K; Omura S
Proc Natl Acad Sci U S A; 2003 Jan; 100(2):473-7. PubMed ID: 12515859
[TBL] [Abstract][Full Text] [Related]
8. Comparison of catalytic activity and inhibitors of quinone reactions of succinate dehydrogenase (Succinate-ubiquinone oxidoreductase) and fumarate reductase (Menaquinol-fumarate oxidoreductase) from Escherichia coli.
Maklashina E; Cecchini G
Arch Biochem Biophys; 1999 Sep; 369(2):223-32. PubMed ID: 10486141
[TBL] [Abstract][Full Text] [Related]
9. Crystal structure of mitochondrial respiratory membrane protein complex II.
Sun F; Huo X; Zhai Y; Wang A; Xu J; Su D; Bartlam M; Rao Z
Cell; 2005 Jul; 121(7):1043-57. PubMed ID: 15989954
[TBL] [Abstract][Full Text] [Related]
10. Iromycins from Streptomyces sp. and from synthesis: new inhibitors of the mitochondrial electron transport chain.
Surup F; Shojaei H; von Zezschwitz P; Kunze B; Grond S
Bioorg Med Chem; 2008 Feb; 16(4):1738-46. PubMed ID: 18054490
[TBL] [Abstract][Full Text] [Related]
11. Manganese ions induce H2O2 generation at the ubiquinone binding site of mitochondrial complex II.
Bonke E; Zwicker K; Dröse S
Arch Biochem Biophys; 2015 Aug; 580():75-83. PubMed ID: 26116786
[TBL] [Abstract][Full Text] [Related]
12. Computational and experimental insight into the molecular mechanism of carboxamide inhibitors of succinate-ubquinone oxidoreductase.
Zhu XL; Xiong L; Li H; Song XY; Liu JJ; Yang GF
ChemMedChem; 2014 Jul; 9(7):1512-21. PubMed ID: 24678033
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of chorismate-utilising enzymes by 2-amino-4-carboxypyridine and 4-carboxypyridone and 5-carboxypyridone analogues.
Payne RJ; Bulloch EM; Kerbarh O; Abell C
Org Biomol Chem; 2010 Aug; 8(15):3534-42. PubMed ID: 20532401
[TBL] [Abstract][Full Text] [Related]
14. Reactive oxygen species production induced by pore opening in cardiac mitochondria: The role of complex II.
Korge P; John SA; Calmettes G; Weiss JN
J Biol Chem; 2017 Jun; 292(24):9896-9905. PubMed ID: 28450394
[TBL] [Abstract][Full Text] [Related]
15. Siccanin rediscovered as a species-selective succinate dehydrogenase inhibitor.
Mogi T; Kawakami T; Arai H; Igarashi Y; Matsushita K; Mori M; Shiomi K; Omura S; Harada S; Kita K
J Biochem; 2009 Sep; 146(3):383-7. PubMed ID: 19505951
[TBL] [Abstract][Full Text] [Related]
16. Discovery of Potent Succinate-Ubiquinone Oxidoreductase Inhibitors via Pharmacophore-linked Fragment Virtual Screening Approach.
Xiong L; Zhu XL; Gao HW; Fu Y; Hu SQ; Jiang LN; Yang WC; Yang GF
J Agric Food Chem; 2016 Jun; 64(24):4830-7. PubMed ID: 27225833
[TBL] [Abstract][Full Text] [Related]
17. Synthesis and characterization of Deltalac-acetogenins that potently inhibit mitochondrial complex I.
Chapuis JC; Khdour O; Cai X; Lu J; Hecht SM
Bioorg Med Chem; 2009 Mar; 17(6):2204-9. PubMed ID: 19027304
[TBL] [Abstract][Full Text] [Related]
18. Crucial structural factors and mode of action of polyene amides as inhibitors for mitochondrial NADH-ubiquinone oxidoreductase (complex I).
Yoshida T; Murai M; Abe M; Ichimaru N; Harada T; Nishioka T; Miyoshi H
Biochemistry; 2007 Sep; 46(36):10365-72. PubMed ID: 17685634
[TBL] [Abstract][Full Text] [Related]
19. Structure-Based Discovery of Potential Fungicides as Succinate Ubiquinone Oxidoreductase Inhibitors.
Xiong L; Li H; Jiang LN; Ge JM; Yang WC; Zhu XL; Yang GF
J Agric Food Chem; 2017 Feb; 65(5):1021-1029. PubMed ID: 28110534
[TBL] [Abstract][Full Text] [Related]
20. Target identification of drug induced mitochondrial toxicity using immunocapture based OXPHOS activity assays.
Nadanaciva S; Bernal A; Aggeler R; Capaldi R; Will Y
Toxicol In Vitro; 2007 Aug; 21(5):902-11. PubMed ID: 17346924
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
